nodes	percent_of_prediction	percent_of_DWPC	metapath
Raltegravir—UGT1A1—Etoposide—uterine cancer	0.344	1	CbGbCtD
Raltegravir—CCR1—myometrium—uterine cancer	0.0265	0.165	CbGeAlD
Raltegravir—CCR1—decidua—uterine cancer	0.0197	0.122	CbGeAlD
Raltegravir—CCR1—endometrium—uterine cancer	0.0187	0.116	CbGeAlD
Raltegravir—CCR1—mammalian vulva—uterine cancer	0.018	0.112	CbGeAlD
Raltegravir—CCR1—uterus—uterine cancer	0.0172	0.107	CbGeAlD
Raltegravir—CCR1—female reproductive system—uterine cancer	0.0155	0.0963	CbGeAlD
Raltegravir—CCR1—female gonad—uterine cancer	0.0141	0.0876	CbGeAlD
Raltegravir—CCR1—vagina—uterine cancer	0.014	0.0871	CbGeAlD
Raltegravir—CCR1—lymph node—uterine cancer	0.00904	0.0563	CbGeAlD
Raltegravir—UGT1A1—renal system—uterine cancer	0.00793	0.0494	CbGeAlD
Raltegravir—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000435	0.000879	CcSEcCtD
Raltegravir—Hot flush—Doxorubicin—uterine cancer	0.000434	0.000878	CcSEcCtD
Raltegravir—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000434	0.000876	CcSEcCtD
Raltegravir—Increased appetite—Doxorubicin—uterine cancer	0.000432	0.000874	CcSEcCtD
Raltegravir—Affect lability—Epirubicin—uterine cancer	0.000432	0.000873	CcSEcCtD
Raltegravir—Migraine—Epirubicin—uterine cancer	0.000432	0.000873	CcSEcCtD
Raltegravir—Menopausal symptoms—Doxorubicin—uterine cancer	0.000431	0.00087	CcSEcCtD
Raltegravir—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00043	0.000869	CcSEcCtD
Raltegravir—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00043	0.000868	CcSEcCtD
Raltegravir—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000427	0.000863	CcSEcCtD
Raltegravir—Renal impairment—Doxorubicin—uterine cancer	0.000427	0.000863	CcSEcCtD
Raltegravir—Malaise—Etoposide—uterine cancer	0.000425	0.00086	CcSEcCtD
Raltegravir—Face oedema—Epirubicin—uterine cancer	0.000424	0.000857	CcSEcCtD
Raltegravir—Vertigo—Etoposide—uterine cancer	0.000424	0.000856	CcSEcCtD
Raltegravir—Abdominal pain—Dactinomycin—uterine cancer	0.000421	0.00085	CcSEcCtD
Raltegravir—Body temperature increased—Dactinomycin—uterine cancer	0.000421	0.00085	CcSEcCtD
Raltegravir—Mood swings—Epirubicin—uterine cancer	0.000416	0.000841	CcSEcCtD
Raltegravir—Lethargy—Doxorubicin—uterine cancer	0.000415	0.000838	CcSEcCtD
Raltegravir—Cough—Etoposide—uterine cancer	0.000412	0.000832	CcSEcCtD
Raltegravir—Blood creatinine increased—Epirubicin—uterine cancer	0.000411	0.000831	CcSEcCtD
Raltegravir—Hypertension—Etoposide—uterine cancer	0.000407	0.000823	CcSEcCtD
Raltegravir—Pain in extremity—Doxorubicin—uterine cancer	0.000406	0.000821	CcSEcCtD
Raltegravir—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000405	0.000819	CcSEcCtD
Raltegravir—Dry skin—Epirubicin—uterine cancer	0.000403	0.000813	CcSEcCtD
Raltegravir—Chest pain—Etoposide—uterine cancer	0.000402	0.000812	CcSEcCtD
Raltegravir—Abdominal pain upper—Epirubicin—uterine cancer	0.000401	0.00081	CcSEcCtD
Raltegravir—Affect lability—Doxorubicin—uterine cancer	0.0004	0.000808	CcSEcCtD
Raltegravir—Migraine—Doxorubicin—uterine cancer	0.0004	0.000808	CcSEcCtD
Raltegravir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000399	0.000806	CcSEcCtD
Raltegravir—Discomfort—Etoposide—uterine cancer	0.000397	0.000802	CcSEcCtD
Raltegravir—Breast disorder—Epirubicin—uterine cancer	0.000397	0.000802	CcSEcCtD
Raltegravir—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.000395	0.000799	CcSEcCtD
Raltegravir—Nasopharyngitis—Epirubicin—uterine cancer	0.000393	0.000793	CcSEcCtD
Raltegravir—Face oedema—Doxorubicin—uterine cancer	0.000392	0.000793	CcSEcCtD
Raltegravir—Hypersensitivity—Dactinomycin—uterine cancer	0.000392	0.000792	CcSEcCtD
Raltegravir—Gastritis—Epirubicin—uterine cancer	0.000389	0.000785	CcSEcCtD
Raltegravir—Confusional state—Etoposide—uterine cancer	0.000388	0.000784	CcSEcCtD
Raltegravir—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.000387	0.000783	CcSEcCtD
Raltegravir—Mood swings—Doxorubicin—uterine cancer	0.000385	0.000778	CcSEcCtD
Raltegravir—Infection—Etoposide—uterine cancer	0.000383	0.000773	CcSEcCtD
Raltegravir—Abdominal distension—Epirubicin—uterine cancer	0.000382	0.000772	CcSEcCtD
Raltegravir—Asthenia—Dactinomycin—uterine cancer	0.000382	0.000771	CcSEcCtD
Raltegravir—Blood creatinine increased—Doxorubicin—uterine cancer	0.000381	0.000769	CcSEcCtD
Raltegravir—Influenza—Epirubicin—uterine cancer	0.00038	0.000767	CcSEcCtD
Raltegravir—Thrombocytopenia—Etoposide—uterine cancer	0.000377	0.000762	CcSEcCtD
Raltegravir—Eosinophilia—Epirubicin—uterine cancer	0.000376	0.000759	CcSEcCtD
Raltegravir—Skin disorder—Etoposide—uterine cancer	0.000374	0.000756	CcSEcCtD
Raltegravir—Dry skin—Doxorubicin—uterine cancer	0.000372	0.000753	CcSEcCtD
Raltegravir—Hyperhidrosis—Etoposide—uterine cancer	0.000372	0.000752	CcSEcCtD
Raltegravir—Abdominal pain upper—Doxorubicin—uterine cancer	0.000371	0.00075	CcSEcCtD
Raltegravir—Breast disorder—Doxorubicin—uterine cancer	0.000367	0.000742	CcSEcCtD
Raltegravir—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000366	0.000739	CcSEcCtD
Raltegravir—Bronchitis—Epirubicin—uterine cancer	0.000365	0.000738	CcSEcCtD
Raltegravir—Diarrhoea—Dactinomycin—uterine cancer	0.000364	0.000735	CcSEcCtD
Raltegravir—Nasopharyngitis—Doxorubicin—uterine cancer	0.000363	0.000734	CcSEcCtD
Raltegravir—Gastritis—Doxorubicin—uterine cancer	0.00036	0.000727	CcSEcCtD
Raltegravir—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000358	0.000724	CcSEcCtD
Raltegravir—Neutropenia—Epirubicin—uterine cancer	0.000355	0.000717	CcSEcCtD
Raltegravir—Abdominal distension—Doxorubicin—uterine cancer	0.000354	0.000714	CcSEcCtD
Raltegravir—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000353	0.000713	CcSEcCtD
Raltegravir—Influenza—Doxorubicin—uterine cancer	0.000351	0.00071	CcSEcCtD
Raltegravir—Eosinophilia—Doxorubicin—uterine cancer	0.000348	0.000703	CcSEcCtD
Raltegravir—Paraesthesia—Etoposide—uterine cancer	0.000346	0.000699	CcSEcCtD
Raltegravir—Weight increased—Epirubicin—uterine cancer	0.000345	0.000698	CcSEcCtD
Raltegravir—Weight decreased—Epirubicin—uterine cancer	0.000343	0.000694	CcSEcCtD
Raltegravir—Hyperglycaemia—Epirubicin—uterine cancer	0.000342	0.000692	CcSEcCtD
Raltegravir—Somnolence—Etoposide—uterine cancer	0.000342	0.000692	CcSEcCtD
Raltegravir—Infestation NOS—Epirubicin—uterine cancer	0.000338	0.000684	CcSEcCtD
Raltegravir—Infestation—Epirubicin—uterine cancer	0.000338	0.000684	CcSEcCtD
Raltegravir—Vomiting—Dactinomycin—uterine cancer	0.000338	0.000683	CcSEcCtD
Raltegravir—Bronchitis—Doxorubicin—uterine cancer	0.000338	0.000682	CcSEcCtD
Raltegravir—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000336	0.000678	CcSEcCtD
Raltegravir—Rash—Dactinomycin—uterine cancer	0.000335	0.000678	CcSEcCtD
Raltegravir—Decreased appetite—Etoposide—uterine cancer	0.000335	0.000676	CcSEcCtD
Raltegravir—Renal failure—Epirubicin—uterine cancer	0.000333	0.000672	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Etoposide—uterine cancer	0.000332	0.000672	CcSEcCtD
Raltegravir—Fatigue—Etoposide—uterine cancer	0.000332	0.000671	CcSEcCtD
Raltegravir—Neuropathy peripheral—Epirubicin—uterine cancer	0.000332	0.00067	CcSEcCtD
Raltegravir—Pain—Etoposide—uterine cancer	0.000329	0.000665	CcSEcCtD
Raltegravir—Constipation—Etoposide—uterine cancer	0.000329	0.000665	CcSEcCtD
Raltegravir—Neutropenia—Doxorubicin—uterine cancer	0.000328	0.000664	CcSEcCtD
Raltegravir—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000326	0.000659	CcSEcCtD
Raltegravir—Haematuria—Epirubicin—uterine cancer	0.000323	0.000652	CcSEcCtD
Raltegravir—Hepatobiliary disease—Epirubicin—uterine cancer	0.00032	0.000647	CcSEcCtD
Raltegravir—Weight increased—Doxorubicin—uterine cancer	0.00032	0.000646	CcSEcCtD
Raltegravir—Epistaxis—Epirubicin—uterine cancer	0.000319	0.000645	CcSEcCtD
Raltegravir—Weight decreased—Doxorubicin—uterine cancer	0.000318	0.000642	CcSEcCtD
Raltegravir—Feeling abnormal—Etoposide—uterine cancer	0.000317	0.000641	CcSEcCtD
Raltegravir—Hyperglycaemia—Doxorubicin—uterine cancer	0.000317	0.00064	CcSEcCtD
Raltegravir—Nausea—Dactinomycin—uterine cancer	0.000316	0.000639	CcSEcCtD
Raltegravir—Gastrointestinal pain—Etoposide—uterine cancer	0.000315	0.000636	CcSEcCtD
Raltegravir—Infestation NOS—Doxorubicin—uterine cancer	0.000313	0.000633	CcSEcCtD
Raltegravir—Infestation—Doxorubicin—uterine cancer	0.000313	0.000633	CcSEcCtD
Raltegravir—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.00031	0.000627	CcSEcCtD
Raltegravir—Renal failure—Doxorubicin—uterine cancer	0.000308	0.000622	CcSEcCtD
Raltegravir—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000307	0.00062	CcSEcCtD
Raltegravir—Urticaria—Etoposide—uterine cancer	0.000306	0.000618	CcSEcCtD
Raltegravir—Abdominal pain—Etoposide—uterine cancer	0.000304	0.000615	CcSEcCtD
Raltegravir—Body temperature increased—Etoposide—uterine cancer	0.000304	0.000615	CcSEcCtD
Raltegravir—Hepatitis—Epirubicin—uterine cancer	0.000304	0.000614	CcSEcCtD
Raltegravir—Hypoaesthesia—Epirubicin—uterine cancer	0.000302	0.000611	CcSEcCtD
Raltegravir—Urinary tract disorder—Epirubicin—uterine cancer	0.0003	0.000606	CcSEcCtD
Raltegravir—Oedema peripheral—Epirubicin—uterine cancer	0.000299	0.000605	CcSEcCtD
Raltegravir—Haematuria—Doxorubicin—uterine cancer	0.000299	0.000603	CcSEcCtD
Raltegravir—Connective tissue disorder—Epirubicin—uterine cancer	0.000299	0.000603	CcSEcCtD
Raltegravir—Urethral disorder—Epirubicin—uterine cancer	0.000298	0.000602	CcSEcCtD
Raltegravir—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000296	0.000598	CcSEcCtD
Raltegravir—Epistaxis—Doxorubicin—uterine cancer	0.000295	0.000597	CcSEcCtD
Raltegravir—Visual impairment—Epirubicin—uterine cancer	0.000293	0.000592	CcSEcCtD
Raltegravir—Erythema multiforme—Epirubicin—uterine cancer	0.000287	0.00058	CcSEcCtD
Raltegravir—Eye disorder—Epirubicin—uterine cancer	0.000284	0.000574	CcSEcCtD
Raltegravir—Hypersensitivity—Etoposide—uterine cancer	0.000284	0.000573	CcSEcCtD
Raltegravir—Tinnitus—Epirubicin—uterine cancer	0.000283	0.000572	CcSEcCtD
Raltegravir—Cardiac disorder—Epirubicin—uterine cancer	0.000282	0.00057	CcSEcCtD
Raltegravir—Hepatitis—Doxorubicin—uterine cancer	0.000281	0.000568	CcSEcCtD
Raltegravir—Hypoaesthesia—Doxorubicin—uterine cancer	0.00028	0.000565	CcSEcCtD
Raltegravir—Urinary tract disorder—Doxorubicin—uterine cancer	0.000278	0.000561	CcSEcCtD
Raltegravir—Oedema peripheral—Doxorubicin—uterine cancer	0.000277	0.00056	CcSEcCtD
Raltegravir—Asthenia—Etoposide—uterine cancer	0.000276	0.000558	CcSEcCtD
Raltegravir—Connective tissue disorder—Doxorubicin—uterine cancer	0.000276	0.000558	CcSEcCtD
Raltegravir—Angiopathy—Epirubicin—uterine cancer	0.000276	0.000557	CcSEcCtD
Raltegravir—Urethral disorder—Doxorubicin—uterine cancer	0.000276	0.000557	CcSEcCtD
Raltegravir—Immune system disorder—Epirubicin—uterine cancer	0.000274	0.000554	CcSEcCtD
Raltegravir—Mediastinal disorder—Epirubicin—uterine cancer	0.000274	0.000553	CcSEcCtD
Raltegravir—Chills—Epirubicin—uterine cancer	0.000273	0.000551	CcSEcCtD
Raltegravir—Pruritus—Etoposide—uterine cancer	0.000272	0.00055	CcSEcCtD
Raltegravir—Visual impairment—Doxorubicin—uterine cancer	0.000271	0.000547	CcSEcCtD
Raltegravir—Alopecia—Epirubicin—uterine cancer	0.000268	0.000542	CcSEcCtD
Raltegravir—Mental disorder—Epirubicin—uterine cancer	0.000266	0.000538	CcSEcCtD
Raltegravir—Erythema multiforme—Doxorubicin—uterine cancer	0.000266	0.000537	CcSEcCtD
Raltegravir—Erythema—Epirubicin—uterine cancer	0.000264	0.000534	CcSEcCtD
Raltegravir—Malnutrition—Epirubicin—uterine cancer	0.000264	0.000534	CcSEcCtD
Raltegravir—Diarrhoea—Etoposide—uterine cancer	0.000263	0.000532	CcSEcCtD
Raltegravir—Eye disorder—Doxorubicin—uterine cancer	0.000263	0.000531	CcSEcCtD
Raltegravir—Tinnitus—Doxorubicin—uterine cancer	0.000262	0.00053	CcSEcCtD
Raltegravir—Cardiac disorder—Doxorubicin—uterine cancer	0.000261	0.000527	CcSEcCtD
Raltegravir—Flatulence—Epirubicin—uterine cancer	0.000261	0.000527	CcSEcCtD
Raltegravir—Dysgeusia—Epirubicin—uterine cancer	0.000259	0.000523	CcSEcCtD
Raltegravir—Nervousness—Epirubicin—uterine cancer	0.000257	0.000519	CcSEcCtD
Raltegravir—Back pain—Epirubicin—uterine cancer	0.000256	0.000517	CcSEcCtD
Raltegravir—Angiopathy—Doxorubicin—uterine cancer	0.000255	0.000515	CcSEcCtD
Raltegravir—Dizziness—Etoposide—uterine cancer	0.000255	0.000514	CcSEcCtD
Raltegravir—Immune system disorder—Doxorubicin—uterine cancer	0.000254	0.000513	CcSEcCtD
Raltegravir—Mediastinal disorder—Doxorubicin—uterine cancer	0.000253	0.000512	CcSEcCtD
Raltegravir—Chills—Doxorubicin—uterine cancer	0.000252	0.00051	CcSEcCtD
Raltegravir—Alopecia—Doxorubicin—uterine cancer	0.000248	0.000502	CcSEcCtD
Raltegravir—Mental disorder—Doxorubicin—uterine cancer	0.000246	0.000498	CcSEcCtD
Raltegravir—Ill-defined disorder—Epirubicin—uterine cancer	0.000245	0.000496	CcSEcCtD
Raltegravir—Vomiting—Etoposide—uterine cancer	0.000245	0.000495	CcSEcCtD
Raltegravir—Erythema—Doxorubicin—uterine cancer	0.000245	0.000494	CcSEcCtD
Raltegravir—Malnutrition—Doxorubicin—uterine cancer	0.000245	0.000494	CcSEcCtD
Raltegravir—Anaemia—Epirubicin—uterine cancer	0.000244	0.000494	CcSEcCtD
Raltegravir—Agitation—Epirubicin—uterine cancer	0.000243	0.000491	CcSEcCtD
Raltegravir—Rash—Etoposide—uterine cancer	0.000243	0.000491	CcSEcCtD
Raltegravir—Dermatitis—Etoposide—uterine cancer	0.000243	0.00049	CcSEcCtD
Raltegravir—Headache—Etoposide—uterine cancer	0.000241	0.000487	CcSEcCtD
Raltegravir—Flatulence—Doxorubicin—uterine cancer	0.000241	0.000487	CcSEcCtD
Raltegravir—Dysgeusia—Doxorubicin—uterine cancer	0.00024	0.000484	CcSEcCtD
Raltegravir—Malaise—Epirubicin—uterine cancer	0.000238	0.000482	CcSEcCtD
Raltegravir—Nervousness—Doxorubicin—uterine cancer	0.000238	0.00048	CcSEcCtD
Raltegravir—Vertigo—Epirubicin—uterine cancer	0.000238	0.00048	CcSEcCtD
Raltegravir—Back pain—Doxorubicin—uterine cancer	0.000237	0.000478	CcSEcCtD
Raltegravir—Palpitations—Epirubicin—uterine cancer	0.000234	0.000472	CcSEcCtD
Raltegravir—Cough—Epirubicin—uterine cancer	0.000231	0.000466	CcSEcCtD
Raltegravir—Nausea—Etoposide—uterine cancer	0.000229	0.000462	CcSEcCtD
Raltegravir—Hypertension—Epirubicin—uterine cancer	0.000228	0.000461	CcSEcCtD
Raltegravir—Ill-defined disorder—Doxorubicin—uterine cancer	0.000227	0.000459	CcSEcCtD
Raltegravir—Anaemia—Doxorubicin—uterine cancer	0.000226	0.000457	CcSEcCtD
Raltegravir—Arthralgia—Epirubicin—uterine cancer	0.000225	0.000455	CcSEcCtD
Raltegravir—Chest pain—Epirubicin—uterine cancer	0.000225	0.000455	CcSEcCtD
Raltegravir—Myalgia—Epirubicin—uterine cancer	0.000225	0.000455	CcSEcCtD
Raltegravir—Agitation—Doxorubicin—uterine cancer	0.000225	0.000454	CcSEcCtD
Raltegravir—Anxiety—Epirubicin—uterine cancer	0.000224	0.000453	CcSEcCtD
Raltegravir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000224	0.000452	CcSEcCtD
Raltegravir—Discomfort—Epirubicin—uterine cancer	0.000222	0.000449	CcSEcCtD
Raltegravir—Malaise—Doxorubicin—uterine cancer	0.000221	0.000446	CcSEcCtD
Raltegravir—Dry mouth—Epirubicin—uterine cancer	0.00022	0.000445	CcSEcCtD
Raltegravir—Vertigo—Doxorubicin—uterine cancer	0.00022	0.000444	CcSEcCtD
Raltegravir—Confusional state—Epirubicin—uterine cancer	0.000218	0.00044	CcSEcCtD
Raltegravir—Palpitations—Doxorubicin—uterine cancer	0.000216	0.000437	CcSEcCtD
Raltegravir—Infection—Epirubicin—uterine cancer	0.000214	0.000433	CcSEcCtD
Raltegravir—Cough—Doxorubicin—uterine cancer	0.000214	0.000431	CcSEcCtD
Raltegravir—Nervous system disorder—Epirubicin—uterine cancer	0.000212	0.000428	CcSEcCtD
Raltegravir—Thrombocytopenia—Epirubicin—uterine cancer	0.000211	0.000427	CcSEcCtD
Raltegravir—Hypertension—Doxorubicin—uterine cancer	0.000211	0.000427	CcSEcCtD
Raltegravir—Skin disorder—Epirubicin—uterine cancer	0.00021	0.000424	CcSEcCtD
Raltegravir—Hyperhidrosis—Epirubicin—uterine cancer	0.000209	0.000422	CcSEcCtD
Raltegravir—Chest pain—Doxorubicin—uterine cancer	0.000208	0.000421	CcSEcCtD
Raltegravir—Arthralgia—Doxorubicin—uterine cancer	0.000208	0.000421	CcSEcCtD
Raltegravir—Myalgia—Doxorubicin—uterine cancer	0.000208	0.000421	CcSEcCtD
Raltegravir—Anxiety—Doxorubicin—uterine cancer	0.000208	0.000419	CcSEcCtD
Raltegravir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000207	0.000418	CcSEcCtD
Raltegravir—Discomfort—Doxorubicin—uterine cancer	0.000206	0.000416	CcSEcCtD
Raltegravir—Dry mouth—Doxorubicin—uterine cancer	0.000204	0.000412	CcSEcCtD
Raltegravir—Confusional state—Doxorubicin—uterine cancer	0.000201	0.000407	CcSEcCtD
Raltegravir—Infection—Doxorubicin—uterine cancer	0.000198	0.000401	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000197	0.000397	CcSEcCtD
Raltegravir—Nervous system disorder—Doxorubicin—uterine cancer	0.000196	0.000396	CcSEcCtD
Raltegravir—Thrombocytopenia—Doxorubicin—uterine cancer	0.000196	0.000395	CcSEcCtD
Raltegravir—Insomnia—Epirubicin—uterine cancer	0.000195	0.000394	CcSEcCtD
Raltegravir—Skin disorder—Doxorubicin—uterine cancer	0.000194	0.000392	CcSEcCtD
Raltegravir—Paraesthesia—Epirubicin—uterine cancer	0.000194	0.000392	CcSEcCtD
Raltegravir—Hyperhidrosis—Doxorubicin—uterine cancer	0.000193	0.00039	CcSEcCtD
Raltegravir—Somnolence—Epirubicin—uterine cancer	0.000192	0.000388	CcSEcCtD
Raltegravir—Dyspepsia—Epirubicin—uterine cancer	0.00019	0.000384	CcSEcCtD
Raltegravir—Decreased appetite—Epirubicin—uterine cancer	0.000188	0.000379	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000186	0.000377	CcSEcCtD
Raltegravir—Fatigue—Epirubicin—uterine cancer	0.000186	0.000376	CcSEcCtD
Raltegravir—Pain—Epirubicin—uterine cancer	0.000185	0.000373	CcSEcCtD
Raltegravir—Constipation—Epirubicin—uterine cancer	0.000185	0.000373	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000182	0.000368	CcSEcCtD
Raltegravir—Insomnia—Doxorubicin—uterine cancer	0.000181	0.000365	CcSEcCtD
Raltegravir—Paraesthesia—Doxorubicin—uterine cancer	0.000179	0.000362	CcSEcCtD
Raltegravir—Feeling abnormal—Epirubicin—uterine cancer	0.000178	0.000359	CcSEcCtD
Raltegravir—Somnolence—Doxorubicin—uterine cancer	0.000178	0.000359	CcSEcCtD
Raltegravir—Gastrointestinal pain—Epirubicin—uterine cancer	0.000176	0.000357	CcSEcCtD
Raltegravir—Dyspepsia—Doxorubicin—uterine cancer	0.000176	0.000355	CcSEcCtD
Raltegravir—Decreased appetite—Doxorubicin—uterine cancer	0.000174	0.000351	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000172	0.000348	CcSEcCtD
Raltegravir—Fatigue—Doxorubicin—uterine cancer	0.000172	0.000348	CcSEcCtD
Raltegravir—Urticaria—Epirubicin—uterine cancer	0.000171	0.000346	CcSEcCtD
Raltegravir—Pain—Doxorubicin—uterine cancer	0.000171	0.000345	CcSEcCtD
Raltegravir—Constipation—Doxorubicin—uterine cancer	0.000171	0.000345	CcSEcCtD
Raltegravir—Abdominal pain—Epirubicin—uterine cancer	0.000171	0.000345	CcSEcCtD
Raltegravir—Body temperature increased—Epirubicin—uterine cancer	0.000171	0.000345	CcSEcCtD
Raltegravir—Feeling abnormal—Doxorubicin—uterine cancer	0.000165	0.000333	CcSEcCtD
Raltegravir—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000163	0.00033	CcSEcCtD
Raltegravir—Hypersensitivity—Epirubicin—uterine cancer	0.000159	0.000321	CcSEcCtD
Raltegravir—Urticaria—Doxorubicin—uterine cancer	0.000159	0.000321	CcSEcCtD
Raltegravir—Abdominal pain—Doxorubicin—uterine cancer	0.000158	0.000319	CcSEcCtD
Raltegravir—Body temperature increased—Doxorubicin—uterine cancer	0.000158	0.000319	CcSEcCtD
Raltegravir—Asthenia—Epirubicin—uterine cancer	0.000155	0.000313	CcSEcCtD
Raltegravir—Pruritus—Epirubicin—uterine cancer	0.000153	0.000309	CcSEcCtD
Raltegravir—Diarrhoea—Epirubicin—uterine cancer	0.000148	0.000298	CcSEcCtD
Raltegravir—Hypersensitivity—Doxorubicin—uterine cancer	0.000147	0.000297	CcSEcCtD
Raltegravir—Asthenia—Doxorubicin—uterine cancer	0.000143	0.00029	CcSEcCtD
Raltegravir—Dizziness—Epirubicin—uterine cancer	0.000143	0.000288	CcSEcCtD
Raltegravir—Pruritus—Doxorubicin—uterine cancer	0.000141	0.000285	CcSEcCtD
Raltegravir—Vomiting—Epirubicin—uterine cancer	0.000137	0.000277	CcSEcCtD
Raltegravir—Diarrhoea—Doxorubicin—uterine cancer	0.000137	0.000276	CcSEcCtD
Raltegravir—Rash—Epirubicin—uterine cancer	0.000136	0.000275	CcSEcCtD
Raltegravir—Dermatitis—Epirubicin—uterine cancer	0.000136	0.000275	CcSEcCtD
Raltegravir—Headache—Epirubicin—uterine cancer	0.000135	0.000273	CcSEcCtD
Raltegravir—Dizziness—Doxorubicin—uterine cancer	0.000132	0.000267	CcSEcCtD
Raltegravir—Nausea—Epirubicin—uterine cancer	0.000128	0.000259	CcSEcCtD
Raltegravir—Vomiting—Doxorubicin—uterine cancer	0.000127	0.000257	CcSEcCtD
Raltegravir—Rash—Doxorubicin—uterine cancer	0.000126	0.000254	CcSEcCtD
Raltegravir—Dermatitis—Doxorubicin—uterine cancer	0.000126	0.000254	CcSEcCtD
Raltegravir—Headache—Doxorubicin—uterine cancer	0.000125	0.000253	CcSEcCtD
Raltegravir—Nausea—Doxorubicin—uterine cancer	0.000119	0.00024	CcSEcCtD
